D-0875-2023 Class III Ongoing

Recalled by AVKARE LLC — Pulaski, TN

FDA drug recall D-0875-2023 was initiated by AVKARE LLC on Jun 13, 2023 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity. The recall status is ongoing. Affected quantity: 592 cartons.

Recall details

Product Type
Drugs
Report Date
Jun 21, 2023
Initiation Date
Jun 13, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
592 cartons

Product description

Tranexamic Acid USP Tablets, 650 mg, 30 tablets (3X10) Unit Dose, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-772-13

Reason for recall

Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

Distribution pattern

Nationwide in the USA.

Code information

Lot: 44286 Exp. 02/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0875-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0875-2023. Report a data issue: hello@regdatalab.com.